Pro Share Advisors LLC Vir Biotechnology, Inc. Transaction History

Pro Share Advisors LLC

$39.7 Billion
Q3 2024

A detailed history of Pro Share Advisors LLC transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Pro Share Advisors LLC holds 26,796 shares of VIR stock, worth $190,787. This represents 0.0% of its overall portfolio holdings.

Number of Shares

26,796

Previous 21,355 25.48%

Holding current value

$190,787

Previous $190,000 5.26%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$7.26 - $10.7 $39,501 - $58,218	5,441 Added 25.48%	26,796 $200,000
Q2 2024 Aug 13, 2024	SELL	$7.63 - $12.66 $38,432 - $63,768	-5,037 Reduced 19.09%	21,355 $190,000
Q1 2024 May 08, 2024	BUY	$8.6 - $11.9 $17,501 - $24,216	2,035 Added 8.35%	26,392 $267,000
Q4 2023 Feb 14, 2024	BUY	$7.76 - $10.29 $21,642 - $28,698	2,789 Added 12.93%	24,357 $245,000
Q3 2023 Nov 13, 2023	BUY	$9.14 - $24.62 $118 - $320	13 Added 0.06%	21,568 $202,000
Q2 2023 Aug 10, 2023	BUY	$23.2 - $27.29 $39,277 - $46,201	1,693 Added 8.52%	21,555 $528,000
Q1 2023 May 11, 2023	SELL	$22.26 - $30.85 $85,500 - $118,494	-3,841 Reduced 16.2%	19,862 $462,000
Q4 2022 Feb 02, 2023	BUY	$19.96 - $28.22 $25,708 - $36,347	1,288 Added 5.75%	23,703 $599,000
Q3 2022 Nov 04, 2022	BUY	$18.26 - $31.1 $11,302 - $19,250	619 Added 2.84%	22,415 $431,000
Q2 2022 Aug 01, 2022	SELL	$19.08 - $26.7 $92,404 - $129,308	-4,843 Reduced 18.18%	21,796 $556,000
Q1 2022 May 10, 2022	SELL	$21.19 - $40.01 $143,223 - $270,427	-6,759 Reduced 20.24%	26,639 $685,000
Q4 2021 Feb 08, 2022	SELL	$30.97 - $54.03 $122,052 - $212,932	-3,941 Reduced 10.55%	33,398 $1.4 Million
Q3 2021 Nov 12, 2021	SELL	$34.9 - $54.54 $140,228 - $219,141	-4,018 Reduced 9.72%	37,339 $1.63 Million
Q2 2021 Aug 13, 2021	BUY	$38.75 - $51.0 $314,882 - $414,426	8,126 Added 24.45%	41,357 $1.96 Million
Q1 2021 May 14, 2021	BUY	$26.34 - $83.07 $14,118 - $44,525	536 Added 1.64%	33,231 $1.7 Million
Q4 2020 Feb 09, 2021	BUY	$25.51 - $43.38 $638,005 - $1.08 Million	25,010 Added 325.44%	32,695 $876,000
Q3 2020 Nov 13, 2020	BUY	$28.28 - $53.6 $35,604 - $67,482	1,259 Added 19.59%	7,685 $264,000
Q2 2020 Aug 03, 2020	BUY	$27.89 - $47.86 $179,221 - $307,548	6,426 New	6,426 $263,000

Others Institutions Holding VIR

# of Institutions

219

Shares Held

87.4M

Call Options Held

127K

Put Options Held

1.19M

View Full List

About Vir Biotechnology, Inc.

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $944M
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

More about VIR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Account

Pro Share Advisors LLC Vir Biotechnology, Inc. Transaction History